Florence Delie

Dr. Florence Delie

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MGMarie Gaumet
Marie Gaumet
AVAngelica Vargas
Angelica Vargas
RGRobert Gurny
Robert Gurny
FDFlorence Delie
Florence Delie

30 September 2007 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
AVA Vargas
A Vargas
MZM Zeisserlabouebe
M Zeisserlabouebe
NLN Lange
N Lange
RGR Gurny
R Gurny
FDFlorence Delie
Florence Delie

1 December 2006 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MZMagali Zeisser-Labouèbe
Magali Zeisser-Labouèbe
NLNorbert Lange
Norbert Lange
RGRobert Gurny
Robert Gurny
FDFlorence Delie
Florence Delie

1 November 2004 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AVAngelica Vargas
Angelica Vargas
BPBernadette Pegaz
Bernadette Pegaz
EDElodie Debefve
Elodie Debefve
YKYvette Konan-Kouakou
Yvette Konan-Kouakou
NLNorbert Lange
Norbert Lange
FDFlorence Delie
Florence Delie

31 January 2005 in Molecules
Verified
Journal Article
Open access
PDF file
FDFlorence Delie
Florence Delie
María J. Blanco PrietoMaría J. Blanco Prieto
María J. Blanco Prieto
Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed.

15 June 2010 in Journal of Controlled Release
Verified
Journal Article
Closed access
ACA. Cirstoiu-Hapca
A. Cirstoiu-Hapca
FBF. Buchegger
F. Buchegger
NLN. Lange
N. Lange
LBL. Bossy
L. Bossy
RGR. Gurny
R. Gurny
FDFlorence Delie
Florence Delie